PLUS1
84.40
-3.05 (-3.49%)
-3.05 (-3.49%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Abbott Laboratories | ABT | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -3.05 | -3.49% | 84.40 | 84.07 | 85.67 | 85.54 | 87.45 | 14:10:21 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 32,658 | 3,056,307 | $ 85.13 | $ 260,185,426 | 5,059,008 | 72.36 - 92.45 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:10:24 | 1,300 | $ 84.40 | USD |
Abbott Laboratories Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 149.26B | 1.77B | $ 2.37B | 2.06 | 42.90 | 1.75B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 18.16M | $ 1.28 | 1.52% | 01/14/20 | - | - |
Abbott Laboratories News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/21/2020 | 16:30 | Edgar (US Regulatory) | Annual Report (10-k) |
| 2/21/2020 | 10:57 | PR Newswire (US) | Abbott Declares 385th Consecutive Quarterly Dividend |
| 2/20/2020 | 08:00 | PR Newswire (US) | New Real-World Data Show that Abbott's FreeStyle Libre.. |
| 2/19/2020 | 17:54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 2/19/2020 | 17:54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 2/19/2020 | 17:38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 2/19/2020 | 17:37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 89.42 | 89.93 | 84.07 | 88.43 | 4,256,214 | -5.02 | -5.61% |
| 1 Month | 89.11 | 90.42 | 84.07 | 88.64 | 4,213,387 | -4.71 | -5.29% |
| 3 Months | 85.57 | 92.45 | 83.27 | 87.52 | 4,580,450 | -1.17 | -1.37% |
| 6 Months | 82.58 | 92.45 | 78.51 | 85.08 | 4,522,730 | 1.82 | 2.2% |
| 1 Year | 76.25 | 92.45 | 72.36 | 82.67 | 4,892,874 | 8.15 | 10.69% |
| 3 Years | 45.29 | 92.45 | 42.31 | 65.88 | 5,401,034 | 39.11 | 86.35% |
| 5 Years | 47.27 | 92.45 | 36.00 | 54.95 | 6,015,686 | 37.13 | 78.55% |
Abbott Laboratories Description
| Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. |
